HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and hemorheological effects of buflomedil in diabetic subjects with intermittent claudication.

AbstractBACKGROUND:
Changes in blood rheology have been described in diabetes mellitus. Buflomedil, a vasoactive substance with hemorheological properties, has been widely used in the treatment of intermittent claudication. The aim of this study was to evaluate the effect of buflomedil on clinical and hemorheological parameters in subjects with type 2 diabetes and intermittent claudication.
METHODS:
Forty patients were randomly assigned to oral buflomedil or matching placebo for six months in a double-blind manner. Initial and absolute walking distances were assessed by a standard treadmill testing protocol. Erythrocyte deformability was estimated with a whole blood filtration technique. ADP- and collagen-induced platelet aggregation was assessed with an aggregation profiler. beta-thromboglobulin and platelet factor-4 were measured with radioimmunoassays. All tests were performed at baseline and after three and six months of treatment.
RESULTS:
A significant increase in the mean initial (71%) and absolute (68%) walking distance was achieved only in the buflomedil group. ADP- and collagen-induced platelet aggregation was significantly reduced in the buflomedil group, while no significant changes in erythrocyte deformability, beta-thromboglobulin and platelet factor-4 levels were noticed. However, beta-thromboglobulin levels increased significantly in the placebo group.
CONCLUSIONS:
These findings suggest the therapeutic efficacy of buflomedil in diabetic subjects with intermittent claudication. The inhibition of platelet aggregation and the influence on platelet activity exerted by the drug could play an important role in its clinical effect and may be of value in the treatment of such patients.
AuthorsE J Diamantopoulos, M Grigoriadou, G Ifanti, S A Raptis
JournalInternational angiology : a journal of the International Union of Angiology (Int Angiol) Vol. 20 Issue 4 Pg. 337-44 (Dec 2001) ISSN: 0392-9590 [Print] Italy
PMID11782701 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Pyrrolidines
  • Vasodilator Agents
  • buflomedil
Topics
  • Diabetes Mellitus, Type 2 (complications)
  • Double-Blind Method
  • Erythrocyte Deformability (drug effects)
  • Female
  • Hemorheology (drug effects)
  • Humans
  • Intermittent Claudication (blood, complications, drug therapy)
  • Male
  • Middle Aged
  • Platelet Aggregation (drug effects)
  • Pyrrolidines (pharmacology, therapeutic use)
  • Vasodilator Agents (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: